A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia

Ciaran Mulholland; G. Lynch; D J King; Stephen Cooper

doi:10.1177/0269881103017001713

A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia

Ciaran Mulholland
, G. Lynch
, D J King
, Stephen Cooper

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	107-112
Number of pages	6
Journal	Journal of Psychopharmacology
Volume	17(1)
Issue number	1
DOIs	https://doi.org/10.1177/0269881103017001713
Publication status	Published - Mar 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Pharmacology
Psychiatry and Mental health
General Neuroscience

Access to Document

10.1177/0269881103017001713

Cite this

@article{0fcbfa9db32b43e4a30e2e7561951c1a,

title = "A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia",

author = "Ciaran Mulholland and G. Lynch and King, \{D J\} and Stephen Cooper",

year = "2003",

month = mar,

doi = "10.1177/0269881103017001713",

language = "English",

volume = "17(1)",

pages = "107--112",

journal = "Journal of Psychopharmacology",

issn = "0269-8811",

publisher = "Sage Publications Ltd",

number = "1",

}

TY - JOUR

T1 - A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia

AU - Mulholland, Ciaran

AU - Lynch, G.

AU - King, D J

AU - Cooper, Stephen

PY - 2003/3

Y1 - 2003/3

UR - https://www.scopus.com/pages/publications/12244305571

U2 - 10.1177/0269881103017001713

DO - 10.1177/0269881103017001713

M3 - Article

SN - 0269-8811

VL - 17(1)

SP - 107

EP - 112

JO - Journal of Psychopharmacology

JF - Journal of Psychopharmacology

IS - 1

ER -

A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this